Document Detail

Diagnostic and prognostic markers in gliomas - an update.
MedLine Citation:
PMID:  23278177     Owner:  NLM     Status:  Publisher    
Gliomas are the most common primary central nervous system tumour seen in adults. There have been many advances over the last two decades as we widen our search for a molecular basis of gliomagenesis. Many biomarkers have been discovered to be important in the management of gliomas, including 1p19q co-deletion, MGMT promoter methylation, BRAF and IDH1 mutations. In this review, we attempt to summarise the available literature on these biomarkers and their use in the diagnosis and management of gliomas. We pay special attention to the recently discovered IDH1 mutation, which is already proving to be a valuable new marker for favourable prognosis and may also indicate a greater response to therapy. 1p19q co-deletions have been shown to delineate a clinically distinct tumour type and are now routinely tested for in certain situations and can help direct treatment. MGMT promoter methylation is one of the most commonly studied biomarkers in gliomas. It has been shown to be a strong positive prognostic marker in gliomas, with positive tumours being more sensitive to chemotherapy. However, a lack of alternatives means that it is not yet a routine mutation tested for clinically. BRAF mutations are new markers found in pilocytic astrocytomas. Although the prognostic value of such mutations is not yet known, they may play a significant role in the diagnosis and treatment of such tumours. IDH1 mutations are 'the new kid on the block' and seem to play a central role in the pathogenesis of gliomas. They represent an independent and favourable prognostic marker and are a new molecular marker for disease diagnosis. Its role in determining response to chemotherapy is still controversial but with further study, IDH1 mutations may prove to be an invaluable marker in the management of gliomas.
R Ma; N de Pennington; M Hofer; C Blesing; R Stacey
Related Documents :
19949767 - Dissection of a qtl reveals an adaptive, interacting gene complex associated with trans...
24740647 - Premature termination of smarcb1 translation may be followed by reinitiation in schwann...
15695467 - Analysis of flowering pathway integrators in arabidopsis.
25231187 - Pubertal onset in girls is strongly influenced by genetic variation affecting fsh action.
23683487 - Pachyonychia congenita type 2 (jackson-lawler syndrome) or pc-17: case report.
16405157 - Loci affecting long-term hybrid survivorship in louisiana irises: implications for repr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-2
Journal Detail:
Title:  British journal of neurosurgery     Volume:  -     ISSN:  1360-046X     ISO Abbreviation:  Br J Neurosurg     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8800054     Medline TA:  Br J Neurosurg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Neurosurgery, John Radcliffe Hospital , Oxford Racliffe Hospitals Trust, West Wing, Headley Way, Headington , Oxford, UK .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia ...
Next Document:  Clinical approach in familial hypophosphatemic rickets: report of three generations.